Abstract
Nitric oxide (NO) and neurogenic inflammation in dura mater due to nociceptor activation has been implicated for pathophysiology of primary headache disorders. Development of migraine has also been observed in patients treated with ganglion blockage for sympathetic reflex dystrophy. Vasoactive intestinal peptide (VIP) is an antioxidant, anti-inflammatory, and neuroprotective neuropeptide. This study is intended to investigate the effects of VIP on dura mater NO levels and vessel-contraction responses in sympathectomized rats. In the experiments, 30 male rats in five groups were used. Group 1 sympathectomized: under anesthesia, superior cervical sympathetic ganglion was removed via incision at the center line in the neck area. Group 2 sympathectomized + VIP: postoperative VIP of 25 ng/kg/day (0.2 ml) intraperitoneally administered to the rats exposed to the same operations for 5 days. Group 3 sham: ganglia and nerves were exposed but not dissected. Group 4 control: no treatment was done. Group 5 VIP: only VIP was administered for 5 days. Sympathectomy induced a significant increase in dura mater NO levels and VIP decreased NO to control levels and increased the norepinephrine vessel-contraction responses of sympathectomized rats. VIP is an efficient NO modulator in superior cervical ganglionectomized rats.
Similar content being viewed by others
Abbreviations
- cGMP:
-
Cyclic guanosine monophosphate
- CGRP:
-
Calcitonin gene-related peptide
- CNS:
-
Central nervous system
- COX-2:
-
Cyclooxygenase-2
- GTN:
-
Glyceryl trinitrate
- IS:
-
Internal standard
- KH:
-
Krebs–Henseleit
- MMP-9:
-
Matrix metalloproteinase-9
- NE:
-
Norepinephrine
- NO:
-
Nitric oxide
- SCG:
-
Superior cervical ganglionectomized group
- SNS:
-
Sympathetic nervous system
- TNF-alpha:
-
Tumor necrosis factor-alpha
- PACAP:
-
Pituitary adenylate cyclase-activating polypeptide
- VIP:
-
Vasoactive intestinal peptide
References
Arranz A, Gutiérrez-Cañas I, Carrión M et al (2008a) VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol Immunol 45:3065–3073
Arranz A, Abad C, Juarranz Y, Leceta J, Martinez C, Gomariz RP (2008b) Vasoactive intestinal peptide as a healing mediator in Crohn's disease. Neuroimmunomodulation 15:46–53
Beleña J, Petersen I, Cabeza R, Núñez M, Vidal A (2006) Migraine headache: a rare complication after cervicothoracic block. J Headaches Pain 7:367–368
Bergerot A, Reynier-Rebuffel AM, Callebert J, Aubineau P (2000) Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater. Neuroscience 96:205–213
Bolden DA (1996) Sympathectomy induces c-Jun in adult trigeminal neurons: an immunohistochemical and tract-tracing study. Neurosci Lett 214:83–86
Bolden DA, Sternini C, Kruger L (1997) GAP-43 mRNA and calcitonin gene-related peptide mRNA expression in sensory neurons are increased following sympathectomy. Brain Res Bull 42:39–50
Can C, Töre F, Tunçel N, Uysal O, Gürer F, Ak D et al (2004) Protective effect of vasoactive intestinal peptide on testicular torsion–detorsion injury: association with heparin-containing mast cells. Urology 63:195–200
Dogrukol-Ak D, Tore F, Tuncel N (2004) Passage of VIP/PACAP/secretin family across the blood–brain barrier: therapeutic effects. Curr Pharm Des 10:1325–1340
Erden SH, Tunçel N, Aydin Y, Sahintürk V, Koşar M, Tunçel M (1998) The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide on renal tissue injury of rats exposed to hemorrhagic ischemia and retransfusion: a possible interaction mechanism among mast cells and tissue histamine. Ann N Y Acad Sci 865:570–581
Giladi E, Hill JM, Dresner E, Stack CM, Gozes I (2007) Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo. J Mol Neurosci 33:278–283
Gozes I, Furman S (2004) Clinical endocrinology and metabolism. Potential clinical applications of vasoactive intestinal peptide: a selected update. Best Pract Res Clin Endocrinol Metab 18:623–640
Hansen J, Sitarz J, Birk S et al (2006) Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia 26:992–1003
Keller JT, Marfurt CF, Dimlich RV, Tierney BE (1989) Sympathetic innervation of the supratentorial dura mater of the rat. J Comp Neurol 290:310–321
Kim GM, Jin KS, Chung CS (2008) Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine. Cephalalgia 28:1179–1187
Kruuse C, Iversen HK, Jansen-Olesen I, Edvinsson L, Olesen J (2009) Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia. doi:10.1111/j.1468-2982.2009.01963.x
Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32
Neeb L, Reuter U (2007) Nitric oxide in migraine. CNS Neurol Disord Drug Targets 6:258–264
Offenhauser N, Zinck T, Hoffmann J et al (2005) CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia 25:225–236
Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157–171
Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53–64
Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5:304–311
Pincus DW, DiCicco-Bloom EM, Black IB (1990) Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564–567
Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226–236
Said SI (1996) Vasoactive intestinal peptide and nitric oxide: divergent roles in relation to tissue injury. Ann N Y Acad Sci 805:379–387
Said SI, Dickman KG (2000) Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Regul Pept 93:21–29
Said SI, Berisha HI, Pakbaz H (1995) N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide. Neuroscience 65:943–946
Sanchez del Rio M, Reuter U, Moskowitz MA (2000) Central and peripheral mechanisms of migraine. Funct Neurol 15:157–162
Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16–25
Spierings ELH (2003) Headache following cervical sympathectomy and results of a blood flow study in the cat. Headache 43:410–414
Szema AM, Hamidi SA, Lyubsky S et al (2006) Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 291:L880–L886
Tikiz H, Tunçel N, Akin MZ, Gürer F (1992) The effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates in rats exposed to severe hemorrhage. Peptides 13:83–89
Tore F, Reynier-Rebuffel AM, Tuncel N, Callebert J, Aubineau P (2001) Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP. Br J Pharmacol 134:1367–1374
Tunçel N, Töre FC (1998) The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock. Ann N Y Acad Sci 865:586–589
Tunçel N, Töre F, Sahintürk V, Ak D, Tunçel M (2000) Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock. Peptides 21:81–89
Tunçel M, Dogrukol-Ak D, Erkasap N (2001) Modified method for the determination of capillary electrophoresis nitric oxide-correlated nitrate in tissue homogenates. J Chromatogr B Biomed Sci Appl 751:257–263
Tunçel N, Sener E, Cerit C, Karasu U, Gürer F, Sahintürk V et al (2005) Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: brain microdialysis, behavior, and microscopy. Peptides 26:827–836
Yildiz SK, Yildiz N, Korkmaz B, Altunrende B, Gezici AR, Alkoy S (2008) Sympathetic skin responses from frontal region in migraine headache: a pilot study. Cephalalgia 28:696–704
Zinck T, Illum R, Jansen-Olesen I (2006) Increased expression of endothelial and neuronal nitric oxide synthase in dura and pia mater after air stress. Cephalalgia 26:14–25
Acknowledgments
This study was presented in Neuropeptide Festival, Joint Meeting of the European Neuropeptide Club and the Summer Neuropeptide Conference, Salzburg, Austria, 20–23 July 2009.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tore, F., Korkmaz, O.T., Dogrukol-Ak, D. et al. The Effects of Vasoactive Intestinal Peptide on Dura Mater Nitric Oxide Levels and Vessel-Contraction Responses in Sympathectomized Rats. J Mol Neurosci 41, 288–293 (2010). https://doi.org/10.1007/s12031-009-9310-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-009-9310-8